Global Rosacea Treatment Market 2018-2022: High Prevalence of Rosacea in Several Countries will Play a Key Factor Behind the Growth of the Market Across the Globe

DUBLIN, Sept. 20, 2018 /PRNewswire/ --

The "Global Rosacea Treatment Market 2018-2022" report has been added to ResearchAndMarkets.com's offering.

The Global Rosacea Treatment Market to grow at a CAGR of 2.46% during the period 2018-2022.

Rosacea is a chronic skin disease that generally affects the white population. The exact cause of rosacea remains unknown. As a result, there is no specific cure for the disease. Research is leading to the introduction of methods to treat the condition by minimizing its symptoms.

Covered in this report

The report covers the present scenario and the growth prospects of the rosacea treatment market. To calculate the market size, the report considers the revenue generated by sales of topical and oral rosacea treatment products across the globe. The report also includes a discussion of the key vendors operating in this market.

Summary

One trend affecting this market is the use of topical treatment. Topical therapy is considered the most convenient and the best treatment of rosacea and most of the medications available in the market are topical medications.

According to the report, one driver influencing this market is the growing rate of incidence of rosacea. The high prevalence of rosacea in several countries will play a key factor behind the growth of the market across the globe.

Further, the report states that one challenge affecting this market is the high competition from generic drugs. The competition between standard reference drug and generic drugs is intense as generics have the same therapeutic activity as the reference drug.

Key vendors

• ALLERGAN
• Bayer
• Bausch Health
• Nestle
• Sol-Gel Technologies

Key questions answered in this report

• What will the market size be in 2022 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the Key vendors?
• What are the strengths and weaknesses of the Key vendors?

Key Topics Covered:

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE
PART 05: MARKET SIZING 2017-2022
PART 06: FIVE FORCES ANALYSIS
PART 07: PIPELINE LANDSCAPE

• Drugs under development

PART 08: MARKET SEGMENTATION BY APPLICATION

• Comparison by application
• Topical
  
• Oral
  
• Market opportunity by application

PART 09: CUSTOMER LANDSCAPE

PART 10: REGIONAL LANDSCAPE

• Regional comparison
• Americas
• EMEA
  
• APAC
  
• Key leading countries
• Market opportunity

PART 11: DECISION FRAMEWORK

PART 12: DRIVERS AND CHALLENGES
PART 13: MARKET TRENDS

• Use of topical treatment
• Shift toward combination products
• Technological advances

PART 14: VENDOR LANDSCAPE

• Overview
• Landscape disruption

PART 15: VENDOR ANALYSIS

• Vendors covered
• Vendor classification
• Market positioning of vendors
  

For more information about this report visit

https://www.researchandmarkets.com/research/xr7k8p/global_rosacea?w=5

Media Contact:

Laura Wood, Senior Manager
[email protected]  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets